Current and future treatment of infantile spasms

Bibliography

• Dulac O, Plouin P, Jambaqué I. Predicting favorable outcome in idiopathic West syndrome. Epilepsia 1993;34(4):747-56
   PubMed Web of Science ®Google Scholar
• Kivity S, Lerman P, Ariel R, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 2004;45:255-62
   PubMed Web of Science ®Google Scholar
• Jambaque I, Chiron C, Dumas C, et al. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 2000;38:151-60
   PubMed Web of Science ®Google Scholar
• O’Callaghan FJ, Lux AL, Darke K, et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia 2011;52(7):1359-64
   PubMed Web of Science ®Google Scholar
• Auvin S, Hartman AL, Desnous B, et al. Diagnosis delay in West syndrome: misdiagnosis and consequences. Eur J Pediatr 2012;171(11):1695-701
   PubMed Web of Science ®Google Scholar
• Eisermann MM, DeLaRaillere A, Dellatolas G, et al. Infantile spasms in Down syndrome--effects of delayed anticonvulsive treatment. Epilepsy Res 2003;55:21-7
   PubMed Web of Science ®Google Scholar
• Napuri S, LE Gall E, Dulac O, et al. Factors associated with treatment lag in infantile spasms. Dev Med Child Neurol 2010;52(12):1164-6
   PubMed Web of Science ®Google Scholar
• Philippi H, Wohlrab G, Bettendorf U, et al. Electroencephalographic evolution of hypsarrhythmia: toward an early treatment option. Epilepsia 2008;49(11):1859-64
   PubMed Web of Science ®Google Scholar
• Jóźwiak S, Kotulska K, Domańska-Pakieła D, et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol 2011;15:424-31
   PubMed Web of Science ®Google Scholar
• Wong M. A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev Neurother 2013;13(6):657-69
   PubMed Web of Science ®Google Scholar
• Veerapandiyan A, Singh P, Mikati MA. Possible induction of West syndrome by oxcarbazepine therapy in a patient with complex partial seizures. Epileptic Disord 2012;14(1):99-103
   PubMed Web of Science ®Google Scholar
• Kaminska A. New antiepileptic drugs in childhood epilepsies: indications and limits. Epileptic Disord 2001;3(Spec No 2):SI37-46
   PubMed Web of Science ®Google Scholar
• Riikonen R. Recent advances in the pharmacotherapy of infantile spasms. CNS Drugs 2014;28(4):279-90
   PubMed Web of Science ®Google Scholar
• Aicardi J, Weinman S, Chevrie JJ, Thieffry S. [Flexion spasms in infants. Study of the urinary excretion of 17-hydroxycorticosteroids and titers of cortisol secretion during their treatment with A.C.T.H]. Arch Fr Pediatr 1967;24(5):521-30
   PubMedGoogle Scholar
• Sorel L, Rucquoy-Ponsar M. Spasm in flexion disease in early childhood with typical and atypical symptomatology and its treatment. Apropos of 192 cases. Int J Neurol 1972;9(1):61-72
   PubMedGoogle Scholar
• Schlumberger E, Dulac O. A simple, effective and well-tolerated treatment regime for West syndrome. Dev Med Child Neurol 1994;36(10):863-72
   PubMed Web of Science ®Google Scholar
• Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97:375-9
   PubMed Web of Science ®Google Scholar
• Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001;57:1416-21
   PubMed Web of Science ®Google Scholar
• Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997;26:389-95
   PubMed Web of Science ®Google Scholar
• Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773-8
   PubMed Web of Science ®Google Scholar
• Lux AL, Edwards SW, Hancock E, et al. The United kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005;4:712-17
   PubMed Web of Science ®Google Scholar
• Darke K, Edwards SW, Hancock E, et al. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child 2010;95(5):382-6
   PubMed Web of Science ®Google Scholar
• Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev 2013;6:CD001770
   PubMedGoogle Scholar
• Lux A, Osborne J. The influence of etiology upon ictal semiology, treatment decisions and long-term outcome in infantile spasms and West syndrome. Epilepsy Res 2006;70S:S77-86
   Web of Science ®Google Scholar
• Djuric M, Kravljanac R, Tadic B, et al. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients. Epilepsia 2014;55(12):1918-25
   PubMed Web of Science ®Google Scholar
• Kroll-Seger J, Kaminska A, Moutard ML, et al. Severe relapse of epilepsy after vigabatrin withdrawal: for how long should we treat symptomatic infantile spasms? Epilepsia 2007;48:612-13
   PubMed Web of Science ®Google Scholar
• Nabbout R, Melki I, Gerbaka B, et al. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 2001;42:1580-3
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Plouin P, Dhondt JL, et al. Clinical and EEG video-polygraphic features of epileptic spasms in a child with dihydropteridine reductase deficiency. Efficiency of hydrocortisone. Epileptic Disord 2000;2:213-17
   PubMed Web of Science ®Google Scholar
• Aicardi J. Treatment of infantile spasms. J Pediatr 1983;103(1):171-2
   PubMed Web of Science ®Google Scholar
• Riikonen R. Cytomegalovirus infection and infantile spasms. Dev Med Child Neurol 1978;20:570-9
   PubMed Web of Science ®Google Scholar
• Sukhudyan BG, Dimova PS, Capuano A, Vigevano F. Dyskinesia as a new adverse effect of hormonal treatment in West syndrome. Epileptic Disord 2014;16(1):5-12
   PubMed Web of Science ®Google Scholar
• Taylor JB, Young WO, Rutar T. Posterior subcapsular cataracts in children receiving adrenocorticotropic hormone (ACTH) for infantile spasms. J Child Neurol 2010;25(8):1017-19
   PubMed Web of Science ®Google Scholar
• Vanhatalo S, Nousiainen I, Eriksson K, et al. Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 2002;43:748-56
   PubMed Web of Science ®Google Scholar
• Gaily E. Vigabatrin monotherapy for infantile spasms. Expert Rev Neurother 2012;12(3):275-86
   PubMed Web of Science ®Google Scholar
• Gaily E, Jonsson H, Lappi M. Visual fields at school-age in children treated with vigabatrin in infancy. Epilepsia 2009;50(2):206-16
   PubMed Web of Science ®Google Scholar
• Westall CA, Wright T, Cortese F, et al. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study. Neurology 2014;83(24):2262-8
   PubMed Web of Science ®Google Scholar
• Riikonen R, Rener-Primec Z, Carmant L, et al. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study. Dev Med Child Neurol 2015;57(1):60-7
   PubMed Web of Science ®Google Scholar
• Jammoul F, Wang Q, Nabbout R, et al. Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Ann Neurol 2009;65(1):98-107
   PubMed Web of Science ®Google Scholar
• Desguerre I, Pinton F, Nabbout R, et al. Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation. Neuropediatrics 2003;34(5):265-9
   PubMed Web of Science ®Google Scholar
• Wheless JW, Carmant L, Bebin M, et al. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 2009;50(2):195-205
   PubMed Web of Science ®Google Scholar
• Dracopoulos A, Widjaja E, Raybaud C, et al. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia 2010;51(7):1297-304
   PubMed Web of Science ®Google Scholar
• Hsieh DT, Thiele EA. Vigabatrin-related magnetic resonance imaging abnormalities in an infant with tuberous sclerosis complex and infantile spasms. J Pediatr 2013;162(1):215
   PubMed Web of Science ®Google Scholar
• Thelle T, Gammelgaard L, Hansen JK, Østergaard JR. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome. Eur J Paediatr Neurol 2011;15(3):260-4
   PubMed Web of Science ®Google Scholar
• Fong CY, Osborne JP, Edwards SW, et al. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Dev Med Child Neurol 2013;55(9):862-7
   PubMed Web of Science ®Google Scholar
• Dill P, Datta AN, Weber P, Schneider J. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms? Eur J Paediatr Neurol 2013;17(3):311-15
   PubMed Web of Science ®Google Scholar
• Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994;35:1154-9
   PubMed Web of Science ®Google Scholar
• Fallah R, Salor F, Akhavan Karbasi S, Motaghipisheh H. Randomised clinical efficacy trial of topiramate and nitrazepam in treatment of infantile spasms. Iran J Child Neurol 2014;8(1):12-19
   PubMedGoogle Scholar
• Mahmoud AA, Rizk TM, Mansy AA, et al. Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids. Open labeled randomized prospective study. Neurosciences (Riyadh) 2013;18(2):143-6
   PubMed Web of Science ®Google Scholar
• Zhu X, Chen O, Zhang D, et al. A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH. Epilepsy Res 2011;93(2-3):149-54
   PubMed Web of Science ®Google Scholar
• Korinthenberg R, Schreiner A. Topiramate in children with West syndrome: a retrospective multicenter evaluation of 100 patients. J Child Neurol 2007;22(3):302-6
   PubMed Web of Science ®Google Scholar
• Yum MS, Ko TS. Zonisamide in West syndrome: an open label study. Epileptic Disord 2009;11(4):339-44
   PubMed Web of Science ®Google Scholar
• Olson HE, Loddenkemper T, Vendrame M, et al. Rufinamide for the treatment of epileptic spasms. Epilepsy Behav 2011;20(2):344-8
   PubMed Web of Science ®Google Scholar
• Chhun S, Troude P, Villeneuve N, et al. A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. Seizure 2011;20(4):320-5
   PubMed Web of Science ®Google Scholar
• Jequier Gygax M, Klein BD, White HS, et al. Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms. Epilepsy Res 2014;108(1):98-108
   PubMed Web of Science ®Google Scholar
• Briggs SW, Mowrey W, Hall CB, Galanopoulou AS. CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms. Epilepsia 2014;55(1):94-102
   PubMed Web of Science ®Google Scholar
• Siemes H, Spohr HL, Michael T, Nau H. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia 1988;29(5):553-60
   PubMed Web of Science ®Google Scholar
• Debus OM, Kurlemann G; Study group. Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication. Epilepsia 2004;45(2):103-8
   PubMed Web of Science ®Google Scholar
• Veggiotti P, Cieuta C, Rex E, Dulac O. Lamotrigine in infantile spasms. Lancet 1994;344(8933):1375-6
   PubMed Web of Science ®Google Scholar
• Hong AM, Turner Z, Hamdy RF, Kossoff EH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia 2010;51(8):1403-7
   PubMed Web of Science ®Google Scholar
• Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet in infantile spasms refractory to first-line treatment. Seizure 2012;21(1):45-8
   PubMed Web of Science ®Google Scholar
• Numis AL, Yellen MB, Chu-Shore CJ, et al. The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms. Epilepsy Res 2011;96(1-2):172-5
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Pyzik PL, McGrogan JR, et al. Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002;109(5):780-3
   PubMed Web of Science ®Google Scholar
• Thiele EA. Managing epilepsy in tuberous sclerosis complex. J Child Neurol 2004;19(9):680-6
   PubMed Web of Science ®Google Scholar
• Pinard JM, Delalande O, Chiron C, et al. Callosotomy for epilepsy after West syndrome. Epilepsia 1999;40:1727-34
   PubMed Web of Science ®Google Scholar
• Geoffroy G, Lassonde M, Delisle F, Décarie M. Corpus callosotomy for control of intractable epilepsy in children. Neurology 1983;33(7):891-7
   PubMed Web of Science ®Google Scholar
• Randò T, Baranello G, Ricci D, et al. Cognitive competence at the onset of West syndrome: correlation with EEG patterns and visual function. Dev Med Child Neurol 2005;47(11):760-5
   PubMed Web of Science ®Google Scholar
• Curatolo P, Maria BL. Tuberous sclerosis. Handb Clin Neurol 2013;111:323-31
   PubMedGoogle Scholar
• Mure T, Nakagawa T, Okizuka Y, et al. Treatment of preterm infants with West syndrome: differences due to etiology. Pediatr Int 2012;54(6):892-8
   PubMed Web of Science ®Google Scholar
• Fukui M, Shimakawa S, Tanabe T, et al. Partial seizures during ACTH therapy in a cryptogenic West syndrome patient. Brain Dev 2014;36(1):80-3
   PubMed Web of Science ®Google Scholar
• Chugani HT, Shields WD, Shewmon DA, et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990;27:406-13
   PubMed Web of Science ®Google Scholar
• Hussain SA, Shinnar S, Kwong G, et al. Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone. Epilepsia 2014;55(1):103-7
   PubMed Web of Science ®Google Scholar
• Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97(3):375-9
   PubMed Web of Science ®Google Scholar
• Mytinger JR, Joshi S; Pediatric Epilepsy Research Consortium; Section on Infantile Spasms. The current evaluation and treatment of infantile spasms among members of the Child Neurology Society. J Child Neurol 2012;27(10):1289-94
   PubMed Web of Science ®Google Scholar
• Scantlebury MH, Galanopoulou AS, Chudomelova L, et al. A model of symptomatic infantile spasms syndrome. Neurobiol Dis 2010;37(3):604-12
   PubMed Web of Science ®Google Scholar
• Mares P, Velísek L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res 1992;65(2):185-9
   PubMedGoogle Scholar
• Marsh E, Fulp C, Gomez E, et al. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 2009;132(6):1563-76
   PubMed Web of Science ®Google Scholar
• Lozovaya N, Gataullina S, Tsintsadze T, et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. Nat Commun 2014;5:4563
   PubMed Web of Science ®Google Scholar
• Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010;51(10):2175-89
   PubMed Web of Science ®Google Scholar
• Galvan CD, Hrachovy RA, Smith KL, Swann JW. Blockade of neuronal activity during hippocampal development produces a chronic focal epilepsy in the rat. J Neurosci 2000;20:2904-16
   PubMed Web of Science ®Google Scholar
• Price MG, Yoo JW, Burgess DL, et al. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioural impairment. J Neurosci 2009;29:8752-63
   PubMed Web of Science ®Google Scholar
• Cortez MA, Shen L, Wu Y, et al. Infantile spasms and Down syndrome: a new animal model. Pediatr Res 2009;65:499-503
   PubMed Web of Science ®Google Scholar
• Briggs SW, Mowrey W, Hall CB, Galanopoulou AS. CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms. Epilepsia 2014;55:94-102
   PubMed Web of Science ®Google Scholar
• Scantlebury MH, Galanopoulou AS, Chudomelova L, et al. A model of symptomatic infantile spasms syndrome. Neurobiol Dis 2010;37:604-12
   PubMed Web of Science ®Google Scholar
• Mares P, Velísek L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res 1992;65:185-9
   PubMedGoogle Scholar
• Macias M, Blazejczyk M, Kazmierska P, et al. Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment. PLoS One 2013;8:e64455
   PubMed Web of Science ®Google Scholar
• Krueger DA, Care MM, Holland K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010;363:1801-11
   PubMed Web of Science ®Google Scholar
• Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008;63(4):444-53
   PubMed Web of Science ®Google Scholar
• Chugani HT, Shewmon DA, Sankar R, et al. Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography. Ann Neurol 1992;31:212-19
   PubMed Web of Science ®Google Scholar
• Desguerre I, Pinton F, Nabbout R, et al. Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation. Neuropediatrics 2003;34:265-9
   PubMed Web of Science ®Google Scholar